MENLO PARK, Calif., Sept. 06, 2016 -- Landec Corporation (Nasdaq:LNDC) will hold a conference call on Wednesday, September 28, 2016 at 8 a.m. Pacific time to discuss its results for the first quarter fiscal 2017. Financial results will be reported for the 2017 fiscal first quarter ended August 28, 2016 after market close on September 27, 2016.
Landec's President and CEO, Molly Hemmeter, will host the Conference Call with Gregory S. Skinner, Vice President and CFO. A question and answer period will follow the presentation.
Date: Wednesday, September 28, 2016
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: (866) 814-1914
U.S. and International Toll Number: (703) 639-1358
Conference ID: 1675982
Webcast: www.Landec.com/earningscall
The webcast will be available for 30 days through October 28, 2016.
A replay of the teleconference will be available for one week until midnight Eastern time, Wednesday, October 5, 2016.
Toll free replay dial in: 888-266-2081
International replay: 703-925-2533
Replay passcode: 1675982
About Landec Corporation
Landec Corporation (NASDAQ:LNDC) is a leading developer and marketer of proprietary health and wellness solutions within the packaged food and biomaterial markets. Apio, Landec’s food business subsidiary, is the leader in branded, packaged fresh vegetables in North America, utilizing its proprietary BreatheWay® packaging technology to naturally extend the shelf life of fresh produce. Apio combines this technology with the capabilities of a large national fresh produce supplier to offer healthy fresh vegetable products under the Eat Smart® brand to consumers through club and retail grocery stores. Lifecore Biomedical, Landec’s biomaterial business, is a fully integrated Contract Development and Manufacturing Organization (CDMO) that offers expertise and capabilities in fermentation, specialty formulation, aseptic filling and final packaging for FDA regulated medical devices and drugs to customers for applications in a wide array of markets including Ophthalmic, Orthopedic and Oncology. For more information about the company, visit Landec’s website at www.landec.com.
CONTACT: Media and Industry Contact: At the Company: Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations: ICR, Inc. John Mills, Partner (646) 277-1254 [email protected]


MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
First Western Ship Transits Strait of Hormuz Since Iran War Began
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 



